Skip to main content

MoneyWorks4Me

Unichem Laboratories - Quaterly Results

05 Nov 2026 Evaluate
The revenue zoomed 12.61% to Rs. 4019.00 millions for the quarter ended September 2026 as compared to Rs. 3569.00 millions during the corresponding quarter last year.The Total Profit for the quarter ended September 2026 of Rs. 14.90 millions grew from Rs.-399.30 millionsOperating profit for the quarter ended September 2026 rose to 327.80 millions as compared to 291.00 millions of corresponding quarter ended September 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 4019.00 3569.00 12.61 7681.70 7411.50 3.65 14122.90 17357.00 -18.63
Other Income 168.50 214.00 -21.26 335.70 256.50 30.88 629.00 408.30 54.05
PBIDT 327.80 291.00 12.65 701.40 590.90 18.70 1132.60 2947.10 -61.57
Interest 17.70 36.80 -51.90 30.60 56.10 -45.45 118.00 76.20 54.86
PBDT 310.10 -77.20 -501.68 670.80 203.40 229.79 3284.40 2910.90 12.83
Depreciation 289.80 301.10 -3.75 576.70 600.40 -3.95 1190.30 1084.10 9.80
PBT 20.30 -378.30 -105.37 94.10 -397.00 -123.70 2094.10 1826.80 14.63
TAX 5.40 21.00 -74.29 23.90 20.80 14.90 504.70 197.20 155.93
Deferred Tax 5.40 21.00 -74.29 23.90 16.40 45.73 500.30 197.20 153.70
PAT 14.90 -399.30 -103.73 70.20 -417.80 -116.80 1589.40 1629.60 -2.47
Equity 140.80 140.80 0.00 140.80 140.80 0.00 140.80 140.80 0.00
PBIDTM(%) 8.16 8.15 0.03 9.13 7.97 14.53 8.02 16.98 -52.77
Peers
Company Name CMP
Sun Pharma. Inds. 1903.00
Dr. Reddys Labs. 1398.00
Cipla 1416.00
Lupin 1999.00
Zydus Lifesciences 1200.00
View more..